Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation

Einav Nili Gal-Yam; Keren Levanon

doi:10.1200/PO.23.00097

Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation

Einav Nili Gal-Yam^*, Keren Levanon

^*Corresponding author for this work

Oncology

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Article number	e2300097
Journal	JCO Precision Oncology
Volume	7
DOIs	https://doi.org/10.1200/PO.23.00097
State	Published - 2023

Funding

Funders	Funder number
Sermonix Pharmaceuticals

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.23.00097

Cite this

@article{507f916f95364fe2a46f36dab6ae16fc,

title = "Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation",

author = "Gal-Yam, {Einav Nili} and Keren Levanon",

year = "2023",

doi = "10.1200/PO.23.00097",

language = "אנגלית",

volume = "7",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation

AU - Gal-Yam, Einav Nili

AU - Levanon, Keren

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85207760031&partnerID=8YFLogxK

U2 - 10.1200/PO.23.00097

DO - 10.1200/PO.23.00097

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 38085049

AN - SCOPUS:85207760031

SN - 2473-4284

VL - 7

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2300097

ER -

Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an ESR1 Mutation

Funding

UN SDGs

Access to Document

Other files and links

Cite this